表柔比星用于晚期黑色素瘤患者的II期试验。 - Suppr

Phase II trial of esorubicin in patients with advanced melanoma.

Frustaci S, Gasparini G, Galligioni E, Tirelli U, Di Pietro N, Crivellari D, Lo Re G, Monfardini S

Cancer Treat Rep. 1987 Mar;71(3):325-6.

Abstract

摘要

Cancer Treat Rep. 1987 Mar;71(3):325-6.

Cancer Treat Rep. 1986 Oct;70(10):1241-2.

Cancer Treat Rep. 1984 Apr;68(4):679-80.

Cancer Treat Rep. 1987 Jul-Aug;71(7-8):765-6.

Cancer Treat Rep. 1987 Jul-Aug;71(7-8):767-8.

Cancer Treat Rep. 1984 Dec;68(12):1509-10.

Cancer Treat Rep. 1986 May;70(5):683-4.

Invest New Drugs. 1986;4(3):269-74. doi: 10.1007/BF00179595.

Cancer Treat Rep. 1985 Nov;69(11):1319-20.

Cancer Treat Rep. 1985 Jan;69(1):143-4.

Invest New Drugs. 1989 Jul;7(2-3):235-8. doi: 10.1007/BF00170865.

Invest New Drugs. 1989 Nov;7(4):333-6. doi: 10.1007/BF00173763.

Invest New Drugs. 1990 Aug;8(3):329-32. doi: 10.1007/BF00171849.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。